NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $59,000 | – | 44,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisors Asset Management, Inc. | 1,148,396 | $8,912,000 | 0.12% |
| WEDBUSH SECURITIES INC | 207,526 | $174,000 | 0.03% |
| MARATHON CAPITAL MANAGEMENT | 55,000 | $46,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $24,000 | 0.01% |
| Virtu KCG Holdings LLC | 30,635 | $26,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $21,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 20,200 | $8,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 3,075 | $3,000 | 0.00% |
| Citadel Advisors | 32,075 | $27,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,800 | $9,000 | 0.00% |